• Study on Spesolimab for Treating Recurrent Flares in Patients with Generalized Pustular Psoriasis

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium France Germany Italy Spain
  • Study on the Safety and Effects of Favezelimab and Pembrolizumab for Patients with Blood Cancers

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany Greece Hungary Italy
  • Long-term Safety Study of Mavacamten for Adults with Hypertrophic Cardiomyopathy from Previous Trials

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Czechia Denmark France Germany Italy +4
  • Study of BMS-986449 and Nivolumab for Patients with Advanced Solid Tumors

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium France Italy The Netherlands Spain
  • Study on the Effectiveness and Safety of LYR-210 and Dexamethasone for Treating Chronic Sinusitis in Adults Without Nasal Polyps

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Belgium Bulgaria Germany Hungary Poland
  • Study on the Effectiveness and Safety of Difelikefalin for Adults with Moderate-to-Severe Itching from Notalgia Paresthetica

    Not recruiting

    4 1
    Investigated diseases:
    Investigated drugs:
    Germany Poland Spain
  • Study on the Effect of Obicetrapib in Patients with Atherosclerotic Cardiovascular Disease Not Adequately Managed by Current Lipid-Lowering Treatments

    Not recruiting

    3 1
    Investigated diseases:
    Investigated drugs:
    Bulgaria Croatia Czechia Denmark Finland Germany +7
  • Study on the Safety and Effects of STAR-0215 for Adults with Hereditary Angioedema

    Not recruiting

    1 1 1
    Investigated drugs:
    Bulgaria Czechia Germany Poland
  • Study on the Safety and Effects of AMB-05X Injections for Patients with Tenosynovial Giant Cell Tumor

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands
  • Study Comparing Odronextamab with Rituximab and Chemotherapy for Patients with Untreated Follicular Lymphoma

    Not recruiting

    3 1 1 1
    Austria Belgium Czechia France Germany Italy +2

powered by